By Femtech Insider Breast Health, Investment, News June 10, 2026 ShareTwitterFacebookPinterest-circled Mammogen Raises Up to $30M for RNA Blood Test That Could Reduce Unnecessary Breast Biopsies
By Femtech Insider Breast Health, Cancer, News, Research June 1, 2026 ShareTwitterFacebookPinterest-circled OPTIMA Trial Finds Gene Test Can Identify Breast Cancer Patients Who Can Safely Forgo Chemotherapy
By Femtech Insider Breast Health, News, Pharma, Regulatory May 26, 2026 ShareTwitterFacebookPinterest-circled FDA Approves DATROWAY for Triple-Negative Breast Cancer, Delivering Median Survival of Two Years
By Femtech Insider Breast Health, Cancer, News, Pharma May 19, 2026 ShareTwitterFacebookPinterest-circled FDA Approves ENHERTU for Early Breast Cancer in Two New Indications
By Femtech Insider Breast Health, Cancer, News May 11, 2026 ShareTwitterFacebookPinterest-circled Artera Receives FDA Clearance for AI-Powered Breast Cancer Risk Stratification Tool
By Femtech Insider Breast Health, Cancer, News May 5, 2026 ShareTwitterFacebookPinterest-circled FDA Approves VEPPANU, a New Class of Targeted Therapy for Advanced Breast Cancer
By Femtech Insider Breast Health, Cancer, Investment, News April 20, 2026 ShareTwitterFacebookPinterest-circled ScreenPoint Medical Raises $16M to Scale AI-Powered Breast Cancer Detection Globally
By Femtech Insider Breast Health, Cancer, News, Pharma March 20, 2026 ShareTwitterFacebookPinterest-circled Novartis Acquires Next-Generation Breast Cancer Drug in $3 Billion Deal
